Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Affective Disorders|September 25, 2013
The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatmentMurat Emul, Nesrin Karamustafalioglu, Tevfik Kalelioglu, et al.
Hematology (Amsterdam, Netherlands)|March 11, 2020
Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patientsZeynep Arzu Yegin, Ferda Can, Lale Aydın Kaynar, et al.
Psychiatry Research|April 29, 2014
Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episodeTevfik Kalelioglu, Abdullah Genc, Nesrin Karamustafalioglu, et al.
Psychiatry and Clinical Neurosciences|October 10, 2014
Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatmentAbdullah Genc, Tevfik Kalelioglu, Nesrin Karamustafalioglu, et al.
Annals of Hematology|September 5, 2024
Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignanciesKamil Inci, Gülbin Aygencel, Onur Gökçe, et al.
Hematology (Amsterdam, Netherlands)|April 5, 2021
Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center studyTuğba Barlas, Kamil İnci, Gulbin Aygencel, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|October 25, 2023
Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective StudyEmine Merve Savaş, Seda Yılmaz, Ayşe Asena Başer Dikyar, et al.
BMC Cancer|October 11, 2025
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry projectIbrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat, et al.
Leukemia Research|May 6, 2026
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature reviewDeniz Özmen, Derya Deniz Kürekçi, Vildan Özkocaman, et al.
Journal of Clinical Medicine|October 29, 2025
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML RegistryVolkan Karakus, Ibrahim Ethem Pinar, Utku Iltar, et al.
Pageof 3